Supplemental Table.
2: Comparison of baseline characteristics, comorbidities, and outcomes in patients with and without cardiac troponin measurement
| No cTn Measured | cTn Measured | P-value | |
|---|---|---|---|
| n | 512 | 820 | |
| Age (median [IQR]) | 54.00 [42.00, 66.00] | 59.50 [47.00, 72.00] | <0.001 |
| Male (%) | 254 (49.6) | 485 (59.1) | 0.001 |
| BMI (median [IQR]) | 27.10 [23.15, 31.70] | 28.00 [24.10, 33.45] | 0.004 |
| Comorbidities | |||
| Atrial Fibrillation (%) | 42 (8.2) | 141 (17.2) | <0.001 |
| Coronary Artery Disease (%) | 87 (17.0) | 241 (29.4) | <0.001 |
| Hypertension (%) | 283 (55.3) | 540 (65.9) | <0.001 |
| Chronic Kidney Disease (%) | 102 (19.9) | 225 (27.4) | 0.002 |
| COPD (%) | 22 (4.3) | 67 (8.2) | 0.008 |
| Diabetes Mellitus (%) | 215 (42.0) | 389 (47.4) | 0.059 |
| Asthma (%) | 66 (12.9) | 105 (12.8) | 1.000 |
| Cancer (%) | 47 (9.2) | 92 (11.2) | 0.275 |
| Stroke (%) | 52 (10.2) | 126 (15.4) | 0.008 |
| Myocardial Infarction (%) | 38 (7.4) | 145 (17.7) | <0.001 |
| Venous Thromboembolism (%) | 48 (9.4) | 121 (14.8) | 0.005 |
| Outcomes | |||
| 60-Day Mortality (%) | 16 (3.1) | 140 (17.1) | <0.001 |
| Severe COVID-19 Infection (%) | 102 (19.9) | 401 (48.9) | <0.001 |
cTn = cardiac troponin; IQR = interquartile range; BMI = body mass index; COPD = chronic obstructive pulmonary disorder